<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>ACKNOWLEDGMENTS</title>
 <p>Dr Aaron Ben-Joseph – Dr Ben-Joseph is funded by the Virginia Keiley Benefaction grant.</p>
 <p>Dr Charles Marshall – Dr Marshall is funded by the Barts Charity.</p>
 <p>Professor Andrew Lees – Professor Lees funded by the Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology and reports consultancies from: Britannia Pharmaceuticals and BIAL Portela. He also reports grants and/or research support from the Frances and Renee Hock Fund, and honoraria from Britannia Pharmaceuticals, Profile Pharma, UCB, Roche, BIAL, STADA Nordic, Nordiclnfu Care, and NeuroDerm.</p>
 <p>Dr Alastair Noyce – Dr. Noyce is funded by the Barts Charity. Dr. Noyce reports additional grants from Parkinson’s UK, Virginia Kieley benefaction, grants and non-financial support from GE Healthcare, and personal fees from Profile, Roche, Biogen, BIAL and Britannia, outside the submitted work.</p>
</ack>
